Skip to content
10-Q

Quarterly Report

LeonaBio, Inc. LONA

0001193125-26-211898

← back to feed
Filed
May 7, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 5, 2026 9.39M sh
Shares Diluted Q1 2026 · Mar 31, 2026 19.03M sh
Shares Diluted restated Q1 2026 · Mar 31, 2025 3.9M sh
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$20.9M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$14.67M
Short Term Investments Q1 2026 · Mar 31, 2026 $34.85M
Short Term Investments Q1 2026 · Dec 31, 2025 $19.06M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $32.83M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $69.28M
Stockholders Equity Q1 2026 · Mar 31, 2026 $49.3M
Stockholders Equity Q1 2026 · Dec 31, 2025 $27.79M
Stockholders Equity Q1 2026 · Mar 31, 2025 $37.33M
Stockholders Equity Q1 2026 · Dec 31, 2024 $44.84M
Current Liabilities Q1 2026 · Mar 31, 2026 $6.67M
Current Liabilities Q1 2026 · Dec 31, 2025 $47.5M
Total Liabilities Q1 2026 · Mar 31, 2026 $22.29M
Total Liabilities Q1 2026 · Dec 31, 2025 $64.36M
Current Assets Q1 2026 · Mar 31, 2026 $69.2M
Current Assets Q1 2026 · Dec 31, 2025 $89.46M
Total Assets Q1 2026 · Mar 31, 2026 $71.59M
Total Assets Q1 2026 · Dec 31, 2025 $92.15M
Eps Diluted Q1 2026 · Mar 31, 2026 −$1.73
Eps Diluted restated Q1 2026 · Mar 31, 2025 −$2.34
Eps Basic Q1 2026 · Mar 31, 2026 −$1.73
Eps Basic restated Q1 2026 · Mar 31, 2025 −$2.34
Sga Expense Q1 2026 · Mar 31, 2026 $6.88M
Sga Expense Q1 2026 · Mar 31, 2025 $5.23M
Rd Expense Q1 2026 · Mar 31, 2026 $11.26M
Rd Expense Q1 2026 · Mar 31, 2025 $4.3M
Net Income Q1 2026 · Mar 31, 2026 −$32.95M
Net Income Q1 2026 · Mar 31, 2025 −$9.14M
Operating Income Q1 2026 · Mar 31, 2026 −$17.21M
Operating Income Q1 2026 · Mar 31, 2025 −$9.54M